Postural tachycardia syndrome (POTS)

Circulation. 2013 Jun 11;127(23):2336-42. doi: 10.1161/CIRCULATIONAHA.112.144501.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adult
  • Androstenes
  • Anxiety / diagnosis
  • Anxiety / etiology
  • Blood Volume
  • Cardiovascular Agents / therapeutic use
  • Catheter Ablation
  • Combined Modality Therapy
  • Confusion / etiology
  • Confusion / physiopathology
  • Contraindications
  • Diagnosis, Differential
  • Fatigue / etiology
  • Fatigue / physiopathology
  • Female
  • Hemodynamics
  • Humans
  • Leg / blood supply
  • Mast Cells / metabolism
  • Norepinephrine / blood
  • Norepinephrine Plasma Membrane Transport Proteins / deficiency
  • Norepinephrine Plasma Membrane Transport Proteins / genetics
  • Posture* / physiology
  • Renin-Angiotensin System / physiology
  • Sodium Chloride / therapeutic use
  • Sympathetic Nervous System / physiopathology*
  • Syncope / etiology
  • Syncope / physiopathology
  • Syndrome
  • Tachycardia / etiology*
  • Tachycardia / genetics
  • Tachycardia / physiopathology
  • Tachycardia / psychology
  • Tachycardia / therapy

Substances

  • Androstenes
  • Cardiovascular Agents
  • Norepinephrine Plasma Membrane Transport Proteins
  • SLC6A2 protein, human
  • Sodium Chloride
  • drospirenone
  • Norepinephrine